News & Articles

The high-throughput system enables laboratories to double or even triple their testing capacity

The partnership enables LUMICKS to expand on the implementation of the z-Movi to new immunotherapeutic settings

Crosslinking mass spectrometry (XL-MS) can leverage the PhoX Crosslinker and TIMS/PASEF methods with the large-scale use of accurate collision cross sections

Avacta appoints BBI Solutions as manufacturing partner for the rapid SARS-CoV-2 antigen test being developed with Cytiva

The QuamNESS consortium unites researchers in University of Bristol, Queens University of Belfast and Trinity College Dublin to explore the thermodynamics of quantum machines and technologies, thanks to a major grant boost

BLENREP is the fifth major medicine approval for GSK in 2020

With this numerical result expressed as index value, clinicians will be better equipped to evaluate the duration and level of an individual’s immune response

JULABO USA announces the introduction of 'LucaVision' - a revolutionary new approach to customer service based on Augmented Reality from Atheer

The vDelivery service platform now offering free, expert support to get JULABO temperature control units up and running quickly, with more ways to connect virtually

New seed varieties introduced with high levels of CBG and a THC-level of below 0.2%

The new devices are designed to be ideal for applications sensitive to magnetic fields

This novel system could offer financial protection from fluctuations in market prices or changes in demand, and mitigate risks associated with an unreliable climate

Smart home technologies are an emerging market, with some households installing voice controlled appliances and smart security

Post-menopausal women with lower levels of the female sex hormone estrogen appear to be at higher risk of developing serious complications of COVID-19

Rice is the most widely consumed staple food source for a large part of the world’s population

AI applied to tumor microscopy images detects patterns of 167 different mutations and predicts patient survival in 28 cancer types